# Clustering Approach 2 : METHLYATION_CNMF
Index	Clinical feature name	Test type	P value	Comment
1	Time to Death	logrank test	0.00166836696351769	Range of duration = 0.1 to 98.76, nDeath = 59, nCensor = 64
2	AGE	ANOVA	0.150555575351888	Range of values = 18 to 90, Mean = 56.5024, StdDev = 15.9969, nMissing = 4
3	PRIMARY.SITE.OF.DISEASE	Chi-square test	0.478733562089463	nTypes = 4 (DISTANT METASTASIS/PRIMARY TUMOR/REGIONAL CUTANEOUS OR SUBCUTANEOUS TISSUE (INCLUDES SATELLITE AND IN-TRANSIT METASTASIS)/REGIONAL LYMPH NODE), nPatients = 29/28/38/116
4	GENDER	Fisher's exact test	0.179513557161193	nTypes = 2 (FEMALE/MALE), nPatients = 80/131
5	RADIATIONS.RADIATION.REGIMENINDICATION	Fisher's exact test	0.632277375904363	nTypes = 2 (NO/YES), nPatients = 3/208
6	DISTANT.METASTASIS	Chi-square test	0.397100240936767	nTypes = 5 (M0/M1/M1A/M1B/M1C), nPatients = 185/2/2/2/3, nMissing = 17
7	LYMPH.NODE.METASTASIS	Chi-square test	0.575406184384982	nTypes = 10 (N0/N1/N1A/N1B/N2/N2A/N2B/N2C/N3/NX), nPatients = 114/3/9/17/1/5/15/6/21/5, nMissing = 15
8	TUMOR.STAGECODE	ANOVA	NA	Range of values = Inf to -Inf, Mean = NaN, StdDev = NA, nMissing = 211
9	NEOPLASM.DISEASESTAGE	Chi-square test	0.383232389564182	nTypes = 13 (I OR II NOS/STAGE I/STAGE IA/STAGE IB/STAGE II/STAGE IIA/STAGE IIB/STAGE IIC/STAGE III/STAGE IIIA/STAGE IIIB/STAGE IIIC/STAGE IV), nPatients = 4/18/10/16/20/10/10/24/10/7/23/29/7, nMissing = 23